Skip to main content
. 2009 Jun 24;16(8):1236–1246. doi: 10.1128/CVI.00431-08

TABLE 8.

Bioequivalence of the slope for the anti-HBs in-house assay compared to the AUSAB RIAa

Equivalence range lower specification Equivalence range upper specification Equivalence
0.50 2.00 Yes
0.67 1.50 Yes
0.80 1.25 Yes
0.90 1.11 Yes
a

Shown are the results of Deming regression (ultrastructural model) with CVs of 11.86% for the RIA and the anti-HBS in-house assay. The regression represents a test of bioequivalence on the slope.